Tae-Hwan Kim

Title: **Inventor Tae-Hwan Kim: Pioneering Innovations in Newcastle Disease Research**

Introduction

Tae-Hwan Kim is a notable inventor based in Chungcheongnam-do, South Korea. With two patents to his name, he has significantly contributed to the field of veterinary medicine, particularly concerning Newcastle disease virus (NDV). His innovations are vital for developing effective vaccines and diagnostic methods for this viral infection in avian species.

Latest Patents

Tae-Hwan Kim's latest patents showcase his expertise in recombinant technology and vaccine development. The first patent, titled “Attenuated recombinant Newcastle disease virus and vaccine containing the same,” details a recombinant vector for transcribing the NDV genome. This invention outlines a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV. It describes a method for preparing a recombinant NDV that has low pathogenicity yet offers high protective efficiency against Newcastle disease. Additionally, this patent includes a vaccine formulated with the recombinant NDV.

The second patent, focusing on “HN epitope recognized by avian immune system and antigenic variant Newcastle disease viruses carrying changes in the epitope,” delves into the HN protein's epitope in NDV that can be recognized by the avian immune system. This invention provides methods for detecting NDV using the antibody developed against the epitope and discusses antigenic variants of NDV with modifications in the epitope. These advancements are critical for the rapid and precise diagnosis of Newcastle disease, enhancing vaccine efficacy and monitoring infection in birds.

Career Highlights

In his professional journey, Tae-Hwan Kim has been affiliated with innovative companies such as KBNP, Inc. and Biopoa, Inc. These organizations have provided a platform for him to translate his research into practical applications, contributing to advancements in avian health care.

Collaborations

Throughout his career, Tae-Hwan Kim has collaborated with esteemed colleagues, including Sun-Hee Cho and Hyuk-Joon Kwon. These partnerships have facilitated the exchange of knowledge and expertise, further enriching the field and advancing research in Newcastle disease.

Conclusion

Tae-Hwan Kim's contributions to the field of Newcastle disease research through his patents and collaborative efforts mark him as a key figure in veterinary medicine innovation. His work not only leads to better vaccines and diagnostic tools but also enhances our understanding and control of viral diseases affecting avian populations. As the field of veterinary virology continues to evolve, the impact of his innovations will be felt for years to come.